ATE551341T1 - Chinuklidincarbonatderivate und medizinische zusammensetzung davon - Google Patents

Chinuklidincarbonatderivate und medizinische zusammensetzung davon

Info

Publication number: ATE551341T1
Authority: AT; Austria
Prior art keywords: medical composition; carbonate derivatives; quinuclidine; quinuclidine carbonate; derivatives
Prior art date: 2008-08-08

Application number

AT09777321T

Other languages

English (en)

Inventor

Gabriele Amari

Maurizio Delcanale

Original Assignee

Chiesi Farma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-08-08

Filing date

2009-07-21

Publication date

2012-04-15

2009-07-21 Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa

2012-04-15 Application granted granted Critical

2012-04-15 Publication of ATE551341T1 publication Critical patent/ATE551341T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pulmonology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

AT09777321T 2008-08-08 2009-07-21 Chinuklidincarbonatderivate und medizinische zusammensetzung davon ATE551341T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP08162066A EP2154136A1 (de)	2008-08-08	2008-08-08	Chinuclidin-Carbonat-Derivate und medizinische Zusammensetzungen damit
PCT/EP2009/005272 WO2010015324A1 (en)	2008-08-08	2009-07-21	Quinuclidine carbonate derivatives and medicinal composition thereof

Publications (1)

Publication Number	Publication Date
ATE551341T1 true ATE551341T1 (de)	2012-04-15

Family

ID=40228074

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT09777321T ATE551341T1 (de)	2008-08-08	2009-07-21	Chinuklidincarbonatderivate und medizinische zusammensetzung davon

Country Status (31)

Country	Link
US (3)	US8039483B2 (de)
EP (2)	EP2154136A1 (de)
JP (1)	JP2011530489A (de)
KR (1)	KR20110044221A (de)
CN (1)	CN102112474B (de)
AR (1)	AR072994A1 (de)
AT (1)	ATE551341T1 (de)
AU (1)	AU2009278306B2 (de)
CA (1)	CA2733380A1 (de)
CO (1)	CO6351790A2 (de)
CY (1)	CY1112724T1 (de)
DK (1)	DK2313404T3 (de)
EA (1)	EA019166B1 (de)
ES (1)	ES2384914T3 (de)
GE (1)	GEP20135744B (de)
HR (1)	HRP20120394T1 (de)
IL (1)	IL211103A (de)
JO (1)	JO2831B1 (de)
MA (1)	MA32622B1 (de)
ME (1)	ME01283A (de)
MX (1)	MX2011001504A (de)
MY (1)	MY156332A (de)
NZ (1)	NZ590987A (de)
PL (1)	PL2313404T3 (de)
PT (1)	PT2313404E (de)
RS (1)	RS52370B (de)
SI (1)	SI2313404T1 (de)
TW (1)	TWI455938B (de)
UA (1)	UA102857C2 (de)
WO (1)	WO2010015324A1 (de)
ZA (1)	ZA201100963B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2394589T3 (es)	2007-12-14	2013-02-04	Aerodesigns, Inc	Suministro de productos alimenticios transformables en aerosol
EP2154136A1 (de)	2008-08-08	2010-02-17	CHIESI FARMACEUTICI S.p.A.	Chinuclidin-Carbonat-Derivate und medizinische Zusammensetzungen damit
EP2206712A1 (de)	2008-12-23	2010-07-14	CHIESI FARMACEUTICI S.p.A.	Alkaloidaminoester-Derivate und medizinische Zusammensetzung davon
HUE038555T2 (hu)	2010-04-21	2018-10-29	Chiesi Farm Spa	Eljárás csökkentett elektrosztatikus töltéssel rendelkezõ részecskék elõállítására
CN102947299B (zh)	2010-06-22	2015-07-15	奇斯药制品公司	生物碱氨基酯衍生物及其药物组合物
ES2545812T3 (es)	2010-06-22	2015-09-16	Chiesi Farmaceutici S.P.A.	Derivados aminoéster de alcaloides y composición medicinal de estos
CN102947300B (zh)	2010-06-22	2016-09-21	奇斯药制品公司	生物碱氨基酯衍生物及其药物组合物
CN103298470B (zh) *	2010-09-30	2015-06-17	奇斯药制品公司	硬脂酸镁在吸入用干粉制剂中的用途
WO2012052297A1 (en) *	2010-10-20	2012-04-26	Chiesi Farmaceutici S.P.A.	Carbonate derivatives for the treatment of cough
WO2012069275A1 (en)	2010-11-26	2012-05-31	Chiesi Farmaceutici S.P.A.	Glycine derivatives and their use as muscarinic receptor antagonists
CN103917094B (zh) *	2011-03-18	2016-11-09	建新公司	葡萄糖基神经酰胺合酶抑制剂
BR112013025682A2 (pt)	2011-04-29	2017-01-03	Chiesi Farm Spa	Compostos, composição farmacêutica, uso de um composto, combinação e dispositivo
WO2013098145A1 (en)	2011-12-30	2013-07-04	Chiesi Farmaceutici S.P.A.	Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof
MA37975B2 (fr)	2012-09-11	2021-03-31	Genzyme Corp	Inhibiteurs de synthase de glucosylcéramide
US9427376B2 (en)	2013-10-10	2016-08-30	Chiesi Farmaceutici S.P.A.	Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient
US12527776B2 (en)	2019-02-04	2026-01-20	Genzyme Corporation	Treatment of ciliopathies using inhibitors of glucosylceramide synthase (GCS)
EP4100009A1 (de)	2020-02-03	2022-12-14	Genzyme Corporation	Verfahren zur behandlung neurologischer symptome im zusammenhang mit lysosomalen speicherkrankheiten
KR20230043024A (ko)	2020-07-24	2023-03-30	젠자임 코포레이션	벤글루스타트를 포함하는 제약 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2165768B1 (es) *	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
HUP0303529A3 (en)	2000-12-22	2008-03-28	Almirall Ag	New quinuclidine carbamate derivatives, process for their preparation and pharmaceutical compositions containing them and their use
JP2004532874A (ja) *	2001-04-03	2004-10-28	アリックスセラピューティクス	抗コリン作用性化合物および使用法
JP4505227B2 (ja) *	2001-12-20	2010-07-21	キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ	１−アルキル−１−アゾニアビシクロ［２．２．２］オクタンカルバメート誘導体およびムスカリンレセプターアンタゴニストとしてのそれらの使用
EP1882691A1 (de)	2006-07-26	2008-01-30	CHIESI FARMACEUTICI S.p.A.	Chinuclidinderivate als M3 Antagonisten
EP2154136A1 (de)	2008-08-08	2010-02-17	CHIESI FARMACEUTICI S.p.A.	Chinuclidin-Carbonat-Derivate und medizinische Zusammensetzungen damit
EP2206712A1 (de)	2008-12-23	2010-07-14	CHIESI FARMACEUTICI S.p.A.	Alkaloidaminoester-Derivate und medizinische Zusammensetzung davon
UA107499C2 (uk)	2010-06-22	2015-01-12	Chiesi Farm Spa	Склад сухого порошку, який містить антимускариновий засіб
WO2012052297A1 (en)	2010-10-20	2012-04-26	Chiesi Farmaceutici S.P.A.	Carbonate derivatives for the treatment of cough
US20120220557A1 (en)	2011-02-17	2012-08-30	Chiesi Farmaceutici S.P.A.	Liquid propellant-free formulation comprising an antimuscarinic drug
BR112013025682A2 (pt)	2011-04-29	2017-01-03	Chiesi Farm Spa	Compostos, composição farmacêutica, uso de um composto, combinação e dispositivo

2008
- 2008-08-08 EP EP08162066A patent/EP2154136A1/de not_active Withdrawn
2009
- 2009-07-21 EA EA201100161A patent/EA019166B1/ru not_active IP Right Cessation
- 2009-07-21 JP JP2011521454A patent/JP2011530489A/ja active Pending
- 2009-07-21 DK DK09777321.2T patent/DK2313404T3/da active
- 2009-07-21 ES ES09777321T patent/ES2384914T3/es active Active
- 2009-07-21 MX MX2011001504A patent/MX2011001504A/es active IP Right Grant
- 2009-07-21 EP EP09777321A patent/EP2313404B1/de active Active
- 2009-07-21 UA UAA201101383A patent/UA102857C2/ru unknown
- 2009-07-21 MY MYPI2011000542A patent/MY156332A/en unknown
- 2009-07-21 WO PCT/EP2009/005272 patent/WO2010015324A1/en not_active Ceased
- 2009-07-21 NZ NZ590987A patent/NZ590987A/xx not_active IP Right Cessation
- 2009-07-21 RS RS20120262A patent/RS52370B/sr unknown
- 2009-07-21 PT PT09777321T patent/PT2313404E/pt unknown
- 2009-07-21 CA CA2733380A patent/CA2733380A1/en not_active Abandoned
- 2009-07-21 ME MEP-2011-24A patent/ME01283A/me unknown
- 2009-07-21 HR HRP20120394AT patent/HRP20120394T1/hr unknown
- 2009-07-21 KR KR1020117002974A patent/KR20110044221A/ko not_active Ceased
- 2009-07-21 CN CN200980130187.4A patent/CN102112474B/zh not_active Expired - Fee Related
- 2009-07-21 GE GEAP200912093A patent/GEP20135744B/en unknown
- 2009-07-21 PL PL09777321T patent/PL2313404T3/pl unknown
- 2009-07-21 AT AT09777321T patent/ATE551341T1/de active
- 2009-07-21 AU AU2009278306A patent/AU2009278306B2/en not_active Ceased
- 2009-07-21 SI SI200930266T patent/SI2313404T1/sl unknown
- 2009-07-30 US US12/512,262 patent/US8039483B2/en active Active
- 2009-08-06 JO JO2009296A patent/JO2831B1/en active
- 2009-08-06 TW TW098126682A patent/TWI455938B/zh not_active IP Right Cessation
- 2009-08-07 AR ARP090103053A patent/AR072994A1/es unknown
2011
- 2011-02-07 IL IL211103A patent/IL211103A/en not_active IP Right Cessation
- 2011-02-07 CO CO11013721A patent/CO6351790A2/es active IP Right Grant
- 2011-02-07 ZA ZA2011/00963A patent/ZA201100963B/en unknown
- 2011-03-08 MA MA33683A patent/MA32622B1/fr unknown
- 2011-08-26 US US13/219,109 patent/US8440690B2/en not_active Expired - Fee Related
- 2011-09-14 US US13/232,415 patent/US8404712B2/en not_active Expired - Fee Related
2012
- 2012-05-11 CY CY20121100443T patent/CY1112724T1/el unknown

Also Published As

Publication number	Publication date
HK1156032A1 (en)	2012-06-01
CA2733380A1 (en)	2010-02-11
AU2009278306B2 (en)	2014-06-26
MX2011001504A (es)	2011-03-29
JP2011530489A (ja)	2011-12-22
WO2010015324A1 (en)	2010-02-11
IL211103A (en)	2014-04-30
EP2313404A1 (de)	2011-04-27
EP2313404B1 (de)	2012-03-28
TWI455938B (zh)	2014-10-11
SI2313404T1 (sl)	2012-07-31
CN102112474A (zh)	2011-06-29
EA201100161A1 (ru)	2011-10-31
JO2831B1 (en)	2014-09-15
EA019166B1 (ru)	2014-01-30
CY1112724T1 (el)	2016-02-10
CN102112474B (zh)	2014-01-29
US8440690B2 (en)	2013-05-14
AU2009278306A1 (en)	2010-02-11
ME01283A (me)	2013-06-20
ZA201100963B (en)	2012-05-30
DK2313404T3 (da)	2012-06-04
HRP20120394T1 (hr)	2012-06-30
IL211103A0 (en)	2011-04-28
US8404712B2 (en)	2013-03-26
CO6351790A2 (es)	2011-12-20
EP2154136A1 (de)	2010-02-17
AR072994A1 (es)	2010-10-06
KR20110044221A (ko)	2011-04-28
PL2313404T3 (pl)	2012-09-28
US20110319444A1 (en)	2011-12-29
ES2384914T3 (es)	2012-07-13
PT2313404E (pt)	2012-07-02
MA32622B1 (fr)	2011-09-01
US20120004258A1 (en)	2012-01-05
TW201011022A (en)	2010-03-16
US8039483B2 (en)	2011-10-18
GEP20135744B (en)	2013-02-11
UA102857C2 (en)	2013-08-27
RS52370B (sr)	2012-12-31
NZ590987A (en)	2012-11-30
MY156332A (en)	2016-02-15
US20100035922A1 (en)	2010-02-11

Publication	Publication Date	Title
DK2313404T3 (da)	2012-06-04	Quinuclidin-carbonat-derivater og medicinsk sammensætning deraf
LTPA2018005I1 (lt)	2018-02-12	Farmacinė kompozicija
BRPI0918206A2 (pt)	2015-12-08	derivados de animoéster e composição medicinal destes
BRPI1011587A2 (pt)	2016-03-22	compostos e composições terapèuticas
PT2567707T (pt)	2016-12-27	Composição de péptidos associados a tumores e vacina anticancro relacionada
BRPI0906980A2 (pt)	2015-07-21	Composição de derivados e maleatados
ATE488227T1 (de)	2010-12-15	Feste zubereitung mit alogliptin und pioglitazon
BR112012001532A2 (pt)	2019-09-24	"substituída azolesulfonamides benzoimid e indolesulfonamides substituído como potenciadores mglur4"
BRPI0721651A2 (pt)	2014-04-01	Composição farmacêutica
BRPI0905715A2 (pt)	2015-07-14	Composição farmacêutica e kit de componentes
BRPI0819232A2 (pt)	2016-11-01	composto heterocíclico e composição farmacêutica do mesmo
BRPI0905369A2 (pt)	2015-06-30	Composição farmacêutica, composição e kit compartimentado
EP2236149A4 (de)	2012-12-26	Medizinische zusammensetzung
DE602008001981D1 (de)	2010-09-09	Stellung und therapeutische verwendung
EP2144635A4 (de)	2013-03-20	Sterilisierende zusammensetzung
DK2391349T3 (da)	2014-11-03	Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
EP2298365A4 (de)	2013-01-23	Medizinische zusammensetzung und medizinisches kit
EP2335669A4 (de)	2016-05-11	Zusammensetzung für ein mittel zur desensibilisierung der zähne
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
DK2391351T3 (da)	2014-12-01	Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater
ATE536893T1 (de)	2011-12-15	Zibotentan zusammensetzung mit mannitol und mikrokristalliner zellulose
BRPI0921313A2 (pt)	2015-12-29	composição farmaucêutica
PT2209464E (pt)	2014-09-05	Composição farmacêutica antimalárica
BRPI1006953A2 (pt)	2016-04-26	composição farmacêutica, e, uso de uma composição
ATE499368T1 (de)	2011-03-15	Chinolonverbindung und pharmazeutische zusammensetzung